Pulmicort Respules Suspension
Product Images NDC 0186-1989

11 FDA label images from Astrazeneca Pharmaceuticals Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pulmicort Respules (NDC 0186-1989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure For Pulmicort Respules (Image 01)

Chemical Structure For Pulmicort Respules (Image 01)
Chemical structure diagram of Budesonide, the active ingredient in PULMICORT RESPULES. The illustration shows the molecular framework and functional groups of Budesonide clearly marked with standard chemical notation.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A line graph showing mean change from baseline in nighttime awakenings over a 12-week period. The graph compares four groups: Placebo, Budesonide 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily. The y-axis measures change from baseline, and the x-axis represents time intervals from baseline to weeks 10-12.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A line graph showing mean change from baseline in nighttime asthma symptoms over various weeks of treatment. The graph compares three groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily dosages of the drug.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A line graph depicting the percentage change from baseline in C-reactive protein (CRP) levels over time across various treatment groups. The x-axis represents time points from baseline up to week 12, and the y-axis shows percent change in CRP. Multiple lines show different dosing regimens, including placebo and Budesonide doses at 0.25 mg, 0.5 mg, and 1.0 mg administered once or twice daily.*
FDA Label Image

Figure 1 (Image 05)

Figure 1 (Image 05)
Black and white line drawing showing two hands holding a blister pack, with one hand pulling or opening a single capsule or vial from the pack. This instructional illustration likely demonstrates how to open an individual dose from a multi-dose packaging.*
FDA Label Image

Figure 2 (Image 06)

Figure 2 (Image 06)
Illustration showing a hand holding a vial with an arrow indicating a twisting motion. This instructional diagram likely demonstrates how to open or prepare a vial, possibly for inhalation suspension use.*
FDA Label Image

Figure 3 (Image 07)

Figure 3 (Image 07)
An instructional illustration showing hands opening a PULMICORT RESPULES inhalation suspension vial by twisting off the top cap. An arrow indicates the direction to rotate the cap for removal.*
FDA Label Image

Figure 4 (Image 08)

Figure 4 (Image 08)
An instructional line drawing showing how to insert a small vial or ampule into a respiratory inhalation device. The illustration depicts two hands holding the device and vial, demonstrating the assembly or loading step for inhalation medication delivery.*
FDA Label Image

Pulmicort Respules 0.25 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 09)

Pulmicort Respules 0.25 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 09)
Packaging label for Pulmicort Respules 0.25 mg/2 mL budesonide inhalation suspension. The label indicates 30 single-dose Respules ampules per carton. It includes usage instructions, storage directions to keep at controlled room temperature and upright, manufacturer AstraZeneca Pharmaceuticals LP, and a barcode. The label also notes the product is for inhalation only and is prescription-only.*
FDA Label Image

Pulmicort Respules 0.5 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 10)

Pulmicort Respules 0.5 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 10)
Packaging label for Pulmicort Respules inhalation suspension 0.5 mg/2 mL by AstraZeneca Pharmaceuticals LP. The carton contains 30 single-dose Respules ampules. It includes usage instructions, storage conditions, and a customer service phone number. The label emphasizes that the product is for inhalation only and prescription use (Rx only) and instructs to store the product upright.*
FDA Label Image

Pulmicort Respules 1 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 11)

Pulmicort Respules 1 mg/2 mL Carton Label 30 Single-dose Respules Ampules Per Carton (Image 11)
Packaging label for Pulmicort Respules 1 mg/2 mL inhalation suspension containing budesonide. The label shows it contains 30 single-dose Respules ampules per carton for respiratory inhalation and is intended for prescription use only. Manufactured by AstraZeneca Pharmaceuticals LP, it includes instructions for use, storage guidance to keep upright, and a customer service contact.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.